Evidence map›Paper›PMID 36014382›Full record

ArticleMolecules (Basel, Switzerland)2022

Activation of Nrf2 by Esculetin Mitigates Inflammatory Responses through Suppression of NF-κB Signaling Cascade in RAW 264.7 Cells.

Thanasekaran Jayakumar, Chun-Jen Huang, Ting-Lin Yen, Chih-Wei Hsia, Joen-Rong Sheu, Periyakali Saravana Bhavan, Wei-Chieh Huang, Cheng-Ying Hsieh, Chih-Hsuan Hsia

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Study on the Anti-Inflammatory Mechanism of Coumarins inMolecules (Basel, Switzerland) · 2024
    Article
  11. Mechanisms of PMInternational journal of molecular sciences · 2024
    Article
  12. Article
  13. Article
  14. Esculetin attenuates cerebral ischemia-reperfusion injury and protects neurons through Nrf2 activation in rats.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2024
    Article
  15. Review
  16. Review
  17. Triterpenoid and Coumarin Isolated fromMolecules (Basel, Switzerland) · 2023
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Thanasekaran JayakumarDepartment of Ecology and Environmental Sciences, Pondicherry University, Puducherry 605014, India.
Chun-Jen HuangDepartment of Anesthesiology and Integrative Research Center for Critical Care, Wan Fang Hospital, Taipei Medical University, Taipei 110, Taiwan.
Ting-Lin YenDepartment of Medical Research, Cathay General Hospital, Taipei 106, Taiwan.ORCID 0000-0002-1454-0521
Chih-Wei HsiaGraduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.ORCID 0000-0002-4508-6181
Joen-Rong SheuGraduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.ORCID 0000-0001-8265-3678
Periyakali Saravana BhavanDepartment of Zoology, Bharathiar University, Coimbatore 641046, India.ORCID 0000-0003-2056-4607
Wei-Chieh HuangGraduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.
Cheng-Ying HsiehDepartment of Pharmacology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.
Chih-Hsuan HsiaGraduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.
Taipei Medical University · TWBharathiar University · INCathay General Hospital · TWPondicherry University · INWan Fang Hospital · TW

Funding

Ministry of Science and Technology of Taiwan MOST 110-2320-B-341-001-MY3Ministry of Science and Technology of Taiwan MOST 111-2320-B-038-036Shin Kong Wu Ho-Su Memorial Hospital 2022SKHAND003Taipei Medical University-Wan Fang Hospital 108TMU-WFH-08
6 · The paper itself

Abstract

Inflammation is a major root of several diseases such as allergy, cancer, Alzheimer's, and several others, and the present state of existing drugs provoked researchers to search for new treatment strategies. Plants are regarded to be unique sources of active compounds holding pharmacological properties, and they offer novel designs in the development of therapeutic agents. Therefore, this study aimed to explore the anti-inflammatory mechanism of esculetin in lipoteichoic acid (LTA)-induced macrophage cells (RAW 264.7). The relative expression of inducible nitric oxide synthase (iNOS), nitric oxide (NO) production and COX-2 expression were intensified in LTA-induced RAW cells. The phosphorylation status of mitogen-activated protein kinases (extracellular signal-regulated kinase (ERK)1/2, p38 MAPK, and c-Jun N-terminal kinase (JNK)) and nuclear factor kappa B (NF-κB) p65 were detected by using Western blot assay. The nuclear translocation of p65 was assessed by confocal microscopic image analysis. Esculetin significantly and concentration-dependently inhibited LTA-induced NO production and iNOS expression, but not COX-2 expression, in RAW cells. Esculetin was not effective in LTA-induced MAPK molecules (ERK, p38 and JNK). However, esculetin recovered LTA-induced IκBα degradation and NF-κB p65 phosphorylation. Moreover, esculetin at a higher concentration of 20 µM evidently inhibited the nuclear translocation of NF-κB p65. At the same high concentration, esculetin augmented Nrf2 expression and decreased DPPH radical generation in RAW 264.7 cells. This study exhibits the value of esculetin for the treatment of LTA-induced inflammation by targeting NF-κB signaling pathways via its antioxidant properties.

Indexed as

NF-kappa BAnimalsCyclooxygenase 2InflammationLipopolysaccharidesMiceNF-E2-Related Factor 2Nitric OxideNitric Oxide Synthase Type IIRAW 264.7 CellsSignal TransductionCyclooxygenase 2LipopolysaccharidesNfe2l2 protein, mouseNF-E2-Related Factor 2NF-kappa BNitric OxideNitric Oxide Synthase Type IIanti-inflammationDPPHesculetinMAPK/NF-κBNO/iNOSNrf2

Identifiers

PMID36014382
PMCPMC9412493
OpenAlexW4291512089

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.